Interestingly, the work showed that activation of this signaling axis led to CRELD2 enrichment in the secretome of breast cancer cells and CRELD2‐mediated education of cancer‐associated fibroblasts to a tumor‐promoting form. Here, CRELD2 is linked to breast carcinoma.